Spero Therapeutics, Inc.SPRONASDAQ
LOADING
|||
Net Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Total earnings after all expenses, taxes, and interest
Latest
$-68.57M
↓ 54% below average
Average (9y)
$-44.45M
Historical baseline
Range
High:$22.81M
Low:$-89.76M
CAGR
+23.6%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-68.57M | -400.6% |
| 2023 | $22.81M | +149.1% |
| 2022 | $-46.41M | +48.3% |
| 2021 | $-89.76M | -14.7% |
| 2020 | $-78.28M | -28.5% |
| 2019 | $-60.92M | -46.2% |
| 2018 | $-41.66M | +9.6% |
| 2017 | $-46.10M | -80.8% |
| 2016 | $-25.49M | -151.0% |
| 2015 | $-10.15M | - |